## Endocrine Profile in PCOD **Key Point:** The hallmark endocrine abnormality in PCOD is an elevated LH:FSH ratio (typically >3:1 or even >2:1), with absolute elevation of LH and normal or low FSH levels. ### Pathophysiology of LH Elevation The abnormal GnRH pulsatility in PCOD leads to: 1. Increased frequency and amplitude of GnRH pulses 2. Preferential stimulation of LH over FSH secretion 3. Relative FSH deficiency 4. Impaired follicular development and anovulation **High-Yield:** The elevated LH drives excessive androgen production from theca cells, resulting in the clinical features of hirsutism, acne, and male-pattern baldness. ### Biochemical Consequences | Parameter | PCOD Finding | Clinical Significance | |-----------|--------------|----------------------| | LH | Elevated (often 2–3× normal) | Drives androgen excess | | FSH | Normal or low | Inadequate follicular recruitment | | LH:FSH ratio | >2:1 or >3:1 | Diagnostic clue | | Testosterone | Elevated (mild to moderate) | Causes virilization | | Androstenedione | Elevated | Peripheral conversion to testosterone | **Clinical Pearl:** The elevated LH:FSH ratio is so characteristic that it is used as a diagnostic criterion in Rotterdam criteria and other classification systems for PCOD. ### Why This Occurs The exact mechanism remains incompletely understood, but involves: - Intrinsic ovarian abnormality (increased androgen production) - Insulin resistance and hyperinsulinemia (amplifies LH effect) - Abnormal GnRH secretion pattern - Possible genetic predisposition **Mnemonic:** **LHFS** — **L**uteinizing hormone **H**igh, **F**ollicle-stimulating hormone **S**uppressed (in PCOD).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.